News

Ahead of the UN General Assembly's second high-level meeting on anti-microbial resistance (AMR) this month, about 80 investors or investor representatives, including Legal & General Investment Management and Australian pension fund Hesta, have called for the use of antibiotics in humans, animals and agriculture to be reduced. Investor Action on AMR (IAAMR), which is behind Tuesday's call to arms, said the global costs associated with AMR are likely to reach $100tn and lead to a 3.8 per cent decrease in global GDP by 2050. Jeremy Coller, chair of FAIRR, an investor network with around $75tn in collective assets which raises awareness of the risks in intensive farming and co-founded the IAAMR initiative, said companies from pharma groups to meat producers, took advantage of lax regulations allowing the routine use of antibiotics in animals, enabling them to cut corners in animal welfare while diminishing antibiotic effectiveness in humans". "Investors recognise that AMR is not only a threat to the health of our people and planet, but to the financial wellbeing of those who rely on investment returns to fund their retirements," he added."